iShares LifePath Target Date 2030 ETF (NYSEARCA:ITDB) Stock Price Up 0.6% – Should You Buy?

Shares of iShares LifePath Target Date 2030 ETF (NYSEARCA:ITDBGet Free Report) rose 0.6% during mid-day trading on Friday . The stock traded as high as $32.95 and last traded at $32.85. Approximately 7,632 shares traded hands during mid-day trading, a decline of 32% from the average daily volume of 11,157 shares. The stock had previously closed at $32.67.

iShares LifePath Target Date 2030 ETF Trading Up 0.6%

The stock has a market capitalization of $40.08 million, a P/E ratio of 20.07 and a beta of 0.60. The business has a 50-day moving average price of $33.10 and a two-hundred day moving average price of $31.95.

Institutional Investors Weigh In On iShares LifePath Target Date 2030 ETF

A hedge fund recently bought a new stake in iShares LifePath Target Date 2030 ETF stock. Susquehanna International Group LLP acquired a new stake in iShares LifePath Target Date 2030 ETF (NYSEARCA:ITDBFree Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,166 shares of the company’s stock, valued at approximately $335,000. Susquehanna International Group LLP owned 0.83% of iShares LifePath Target Date 2030 ETF as of its most recent SEC filing.

iShares LifePath Target Date 2030 ETF Company Profile

(Get Free Report)

The iShares LifePath Target Date 2030 ETF (ITDB) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches.

See Also

Receive News & Ratings for iShares LifePath Target Date 2030 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2030 ETF and related companies with MarketBeat.com's FREE daily email newsletter.